TABLE 3.
A summary of financial support and conflicts of interest reported by 78 included clinical practice guidelines
| Category | Guidelines (n) | % |
|---|---|---|
| Status of guideline and update process | ||
| Original, and no mention of future update | 10 | 13 |
| Original, but plans to update in future | 7 | 9 |
| Update and describes update process | 24 | 31 |
| Update and no description of update process | 25 | 32 |
| Unclear | 12 | 15 |
| How was evidence gathered to support recommendations? | ||
| Systematic review—comprehensive (for example, 2+ databases, hand search, experts consulted) | 39 | 50 |
| Systematic review—not comprehensive or not clear (for example, 1 database, no hand search, no experts consulted) | 17 | 22 |
| Informal review (for example, hand search only or insufficient detail) | 8 | 10 |
| Not described | 14 | 18 |
| What methods were used to form recommendations? | ||
| Formal consensus (for example, Delphi method, Glaser techniques) | 15 | 19 |
| Informal consensus or not clear (for example, standard method not mentioned) | 24 | 31 |
| Voting system | 14 | 18 |
| Not described | 25 | 32 |
| Does the guideline clearly present supporting evidence for nutrition recommendations? | ||
| No | 13 | 17 |
| Yes | 65 | 83 |
| Was a funding source named or no funding declared? | ||
| No | 31 | 40 |
| Yes | 47 | 60 |
| Does the guideline state that the views of the funding body have not influenced the content of the guideline? | ||
| No, but funding source was not reported | 31 | 40 |
| No | 29 | 37 |
| Yes | 10 | 13 |
| Not applicable (no funding) | 8 | 10 |
| Were competing interests of guideline development group members disclosed? | ||
| No | 11 | 14 |
| Yes | 67 | 86 |
| Was an attempt made to reduce the effect of competing interests? (for example, excluding certain members from developing guidelines) | ||
| No (disclosed but not mitigated) | 18 | 23 |
| Yes | 21 | 27 |
| Unclear (not addressed) | 39 | 50 |